GB202208773D0 - Anti-SARS2-S antibodies - Google Patents
Anti-SARS2-S antibodiesInfo
- Publication number
- GB202208773D0 GB202208773D0 GBGB2208773.8A GB202208773A GB202208773D0 GB 202208773 D0 GB202208773 D0 GB 202208773D0 GB 202208773 A GB202208773 A GB 202208773A GB 202208773 D0 GB202208773 D0 GB 202208773D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- sars2
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2022/075284 WO2023036982A1 (en) | 2021-09-10 | 2022-09-12 | Anti-sars2-s antibodies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2112933.3A GB202112933D0 (en) | 2021-09-10 | 2021-09-10 | Anti-sars2-s antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202208773D0 true GB202208773D0 (en) | 2022-07-27 |
Family
ID=78149423
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2112933.3A Ceased GB202112933D0 (en) | 2021-09-10 | 2021-09-10 | Anti-sars2-s antibodies |
GBGB2208773.8A Ceased GB202208773D0 (en) | 2021-09-10 | 2022-06-15 | Anti-SARS2-S antibodies |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2112933.3A Ceased GB202112933D0 (en) | 2021-09-10 | 2021-09-10 | Anti-sars2-s antibodies |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB202112933D0 (en) |
-
2021
- 2021-09-10 GB GBGB2112933.3A patent/GB202112933D0/en not_active Ceased
-
2022
- 2022-06-15 GB GBGB2208773.8A patent/GB202208773D0/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
GB202112933D0 (en) | 2021-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT3872091T (en) | Antibodies against sars-cov-2 | |
IL289112A (en) | Anti-tigit antibodies | |
IL308741A (en) | Anti-sirp-alpha antibodies | |
GB201905150D0 (en) | Ant-ige antibodies | |
IL284584A (en) | Anti-tigit antibodies | |
HUE069018T2 (en) | Anti-ccr8 antibodies | |
GB202105110D0 (en) | Anti-CD73 antibodies | |
ZA202209699B (en) | Novel antibodies | |
GB202111905D0 (en) | Antibodies | |
IL300142A (en) | ANTI-IL13Ralpha2 ANTIBODIES | |
EP4217396A4 (en) | Novel anti-claudin18 antibodies | |
GB202014851D0 (en) | SARS-COV-2 antibodies | |
IL299767A (en) | Anti-αlpha-4-βeta-7 antibodies | |
GB201900732D0 (en) | Antibodies | |
GB201917480D0 (en) | Antibodies | |
IL308782A (en) | Antibodies | |
IL308100A (en) | Antibodies | |
EP4324925A4 (en) | Anti-c1s antibody | |
GB202015115D0 (en) | ZIP12 Antibody | |
GB2598698B (en) | Affinity-maturated anti-ASICIa antibodies | |
GB202208773D0 (en) | Anti-SARS2-S antibodies | |
IL307175A (en) | Il-38-specific antibodies | |
GB202116709D0 (en) | Antibodies | |
GB202115824D0 (en) | Antibodies | |
EP4225795A4 (en) | Clec9a antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |